Prot #2215-CL-0103: A Phase 1 Study of ASP2215 in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date4/15/15 → 4/15/23

Funding

  • Astellas Pharma Global Development, Inc. ((OE) Prot #2215-CL-0103)